Media

OptiFreeze har, som meddelats tidigare, bedrivit industriella försök hos ett av Europas största företag inom torkning av grönsaker och örter. Resultatet av dessa tester har varit mycket positiva.

OptiFreeze has, as has previously been informed, been running industrial trials with one of Europe’s largest companies regarding drying of vegetables and herbs. The result of the trials has been very positive.  

The MAR text below fell out: OptiFreeze is taking an important step towards industrial breakthrough with our partner Syngenta, after successful tests with the OptiFreeze technology. As a result of the successful tests the companies have decided to increase the intensity in the common R&D work. OptiFreeze is by that coming closer to an industrial phase in the global market for cuttings.

   In this newsletter we will tell you more about the progress in three different areas of OptiFreeze; an update on our work with Flower Cuttings, exciting news on Cut Flowers and on our ongoing trials in Germany. We hope you will enjoy the information!

OptiFreeze and Syngenta Flowers are publishing a common newsletter starting from this month. The first edition of the newsletter is about “an Introduction to OptiFreeze Technology for Flowers”. 

Tidigare idag, den 28 november 2019, publicerades ett pressmeddelande. I det bifogade pdf-dokumentet hänvisades till marknadsmissbruksförordningen (MAR).  Informationen i pressmeddelandet är regulatorisk men inte av MAR-karaktär. I denna rättelse återfinns det rättade pdf-dokumentet utan hänvisning till marknadsmissbruksförordningen (MAR). Följande sammanfattning avser perioden 2019-01-01 – 2019-09-30 med jämförelseperiod 2018-01-01 – 2018-09-30 · Omsättningen för perioden uppgår till 3 134 257 SEK (923 049 SEK) · Resultatet för perioden uppgår till -5 843 022 SEK (-5 200 335 SEK) · Likvida medel uppgick till 17 107 410 SEK (9 921 882 SEK) · Aktiverade utgifter för forskning och utveckling uppgår till 1 300 758 SEK (1 218 977 SEK) · Genomsnittligt antal aktier uppgår till 10 016 035 stycken (9 877 264 stycken) · Resultat per aktie* -0,58 SEK ( -0,53 SEK) · Soliditet 93,64 % (88,09 %) *Resultat per aktie baseras på genomsnittligt antal aktier under perioden.

Earlier today, November 28, 2019, a press release was incorrectly published. In the enclosed pdf document we referred to the Market Abuse Regulation (MAR). The information in the press release is regulatory but not of a MAR nature. The full press release, including the corrected pdf document without reference to MAR, can be found below. The following summary refers to the period 1/1/2019 – 30/9/2019, compared to 1/1/2018 – 30/9/2018 · Net sales for this period totaled to SEK 3,134,257(SEK 923,049) · Operating result for the period of SEK -5,843,022 (SEK -5,200,335) · Cash and bank balance SEK 17,107,410 (SEK 9,921,882) · Capitalized development costs of SEK 1,300,758 (SEK 1,218,977) · Average number of registered shares 10,016,035 (9,877,264 shares) · Result per share* SEK -0.58 (SEK -0.53) · Equity Ratio 93.64% (88.09%) *Result per share is calculated on the average number of registered shares during the period.

The following summary refers to the period 1/1/2019 – 30/9/2019,  compared to 1/1/2018 – 30/9/2018 · Net sales for this period totaled to SEK 3,134,257(SEK 923,049) · Operating result for the period of SEK -5,843,022 (SEK -5,200,335) · Cash and bank balance SEK 17,107,410 (SEK 9,921,882) · Capitalized development costs of SEK 1,300,758 (SEK 1,218,977) · Average number of registered shares 10,016,035 (9,877,264 shares) · Result per share* SEK -0.58 (SEK -0.53) · Equity Ratio 93.64% (88.09%) *Result per share is calculated on the average number of registered shares during the period.

Sidhänvisningen på sidan 32 under avsnitt "Revisionsberättelse", är ändrad till: "Bolagets årsredovisning ingår på sidorna 10-31 i detta dokument". (Tidigare version: "sidorna 4-17") 

(se bifogad årsredovisning i PDF)